CDK1 and hepatocellular carcinoma: In the case of HCC, miR-582-3p has been demonstrated to be downregulated, and its overexpression reduces cell proliferation and induces cell cycle arrest in the G0/G1 phase by targeting CDK1 and AKT3, suggesting it to be a tumor suppressor [26].